The European Union has unveiled plans to increase massively its supply of the BioNTech/Pfizer coronavirus vaccine, as Denmark became the first European country to end use of the Oxford/AstraZeneca jab.
European Commission president Ursula von der Leyen said 50m doses of the Pfizer shot originally intended for the fourth quarter of 2021 would be delivered between April and June, raising the EU’s anticipated supply of the vaccine in the second quarter to 250m doses.
In addition, Von der Leyen said she had opened negotiations with BioNTech and Pfizer to supply a mammoth 1.8bn additional doses of the vaccine for 2022-2023, as the bloc turns long-term to mRNA-based vaccines and the companies’ jab in particular.
您已阅读15%（713字），剩余85%（3980字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。